At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Escitalopram +1 moredrug
Likely dose
Escitalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial
In Brief
A clinical study evaluating Escitalopram and Placebo for Night Eating Syndrome. Completed, enrolled 40 participants across 2 sites.
Detailed Summary
Night-Eating Syndrome (NES) is an eating disorder characterised by excessive eating at night, sleep disturbance and morning anorexia. This 12-week study examines the effect of escitalopram on symptoms of NES.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNight Eating Syndrome
CountriesUnited States
CollaboratorsSt. Louis University
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 2008
Enrollment StartOct 2008
Primary CompletionAug 2010
Study CompletionJul 2011
TodayJul 2026
First PostedMar 14, 2008
Enrollment StartOct 1, 2008
Primary CompletionAug 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.3 years ago
Interventions
Escitalopramdrug
10-20 mg
Placebodrug
Placebo